Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
The purposes of the study are to determine: i. To assess the efficacy of Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine) ii. To determine the optimal duration for continuation of Tigan® following initiation of Apokyn® therapy iii. To assess the safety of Tigan® in combination with Apokyn® iv. To characterize the pharmacokinetic (PK) profile of apomorphine in subjects treated concomitantly with and without Tigan®
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
The purposes of the study are to determine: i. To assess the efficacy of Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine) ii. To determine the optimal duration for continuation of Tigan® following initiation of Apokyn® therapy iii. To assess the safety of Tigan® in combination with Apokyn® iv. To characterize the pharmacokinetic (PK) profile of apomorphine in subjects treated concomitantly with and without Tigan®
Related Clinical Trials
![A study to evaluate the effect of phenytoin or itraconazole on the circulating levels of IPN60130 in healthy adult participants A study to evaluate the effect of phenytoin or itraconazole on the circulating levels of IPN60130 in healthy adult participants](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
A study to evaluate the effect of phenytoin or itraconazole on the circulating levels of IPN60130 in healthy adult participants
![A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies. A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
![A study to assess whether adding maintenance cabozantinib (XL184) to best supportive care helps children, adolescents and young adults with osteosarcoma. A study to assess whether adding maintenance cabozantinib (XL184) to best supportive care helps children, adolescents and young adults with osteosarcoma.](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
A study to assess whether adding maintenance cabozantinib (XL184) to best supportive care helps children, adolescents and young adults with osteosarcoma.
![A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
![A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
![A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
![A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
![Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
![Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
![Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia. Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)